http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2272012-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d22b649c54d79d7c1eabf23085b14a3e |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
filingDate | 1998-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2007-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f2e7fd7f61e4b29870ddc07af41e99c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbb379380bf4b405feb836f43adf5254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571c44383916ddcb69ecdb7c25aa34e5 |
publicationDate | 2007-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2272012-T3 |
titleOfInvention | FUSION PROTEINS THAT INCLUDE TAT AND / OR NEF PROTEINS OF HIV-1. |
abstract | A vaccine composition comprising a protein comprising (a) a complete HIV Tat protein or Tat with a histidine tail at the C-terminal end, or a mutated Tat that has undergone deletion, addition or substitution of an amino acid, or a mutated Tat as defined in SEQ ID No. 23, attached to (i) a protein or lipropoteic fusion partner or (ii) a complete HIV Nef protein or Nef with a histidine tail at the C-terminal end or Nef that has undergone a deletion, addition or substitution of an amino acid; or (b) a complete HIV Nef protein or Nef with a histidine tail at the C-terminal end, or Nef that has undergone deletion, addition or substitution of an amino acid, bound to (i) a protein or lipoprotein fusion partner either (ii) a complete HIV Tat protein or Tat with a histidine tail at the C-terminal end or to a mutated Tat that has undergone deletion, addition or substitution of an amino acid, or to a mutated Tat as defined in ID SEC No. 23; or (c) a complete HIV Nef protein or Nef with a histidine tail at the C-terminal end, or Nef that has undergone deletion, addition or substitution of an amino acid, bound to a complete HIV Tat protein or Tat with a histidine tail at the C-terminal end or to a mutated Tat that has undergone deletion, addition or substitution of an amino acid, or to a mutated Tat as defined in SEQ ID No. 23 and a protein or lipoprotein fusion partner, mixed with a pharmaceutically acceptable excipient. |
priorityDate | 1997-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.